{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:15:39Z","timestamp":1761894939433},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,7,28]],"date-time":"2009-07-28T00:00:00Z","timestamp":1248739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s10549-009-0479-x","type":"journal-article","created":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T07:03:36Z","timestamp":1248678216000},"page":"347-354","source":"Crossref","is-referenced-by-count":30,"title":["Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers"],"prefix":"10.1007","volume":"121","author":[{"given":"Lindsay A.","family":"Brown","sequence":"first","affiliation":[]},{"given":"Karynn","family":"Johnson","sequence":"additional","affiliation":[]},{"given":"Samuel","family":"Leung","sequence":"additional","affiliation":[]},{"given":"Tarek A.","family":"Bismar","sequence":"additional","affiliation":[]},{"given":"Javier","family":"Ben\u00edtez","sequence":"additional","affiliation":[]},{"given":"William D.","family":"Foulkes","sequence":"additional","affiliation":[]},{"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,7,28]]},"reference":[{"issue":"2","key":"479_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00682720","volume":"33","author":"G Peters","year":"1995","unstructured":"Peters G, Fantl V, Smith R, Brookes S, Dickson C (1995) Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res Treat 33(2):125\u2013135","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"479_CR2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.0.CO;2-N","volume":"20","author":"M Schwab","year":"1998","unstructured":"Schwab M (1998) Amplification of oncogenes in human cancer cells. Bioessays 20(6):473\u2013479","journal-title":"Bioessays"},{"issue":"1\u20132","key":"479_CR3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000134699","volume":"79","author":"S Bekri","year":"1997","unstructured":"Bekri S, Adelaide J, Merscher S, Grosgeorge J, Caroli-Bosc F, Perucca-Lostanlen D, Kelley PM, Pebusque MJ, Theillet C, Birnbaum D et al (1997) Detailed map of a region commonly amplified at 11q13\u2013>q14 in human breast carcinoma. Cytogenet Cell Genet 79(1\u20132):125\u2013131","journal-title":"Cytogenet Cell Genet"},{"issue":"19","key":"479_CR4","first-page":"4360","volume":"57","author":"F Courjal","year":"1997","unstructured":"Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R, Rodriguez C, Theillet C (1997) Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res 57(19):4360\u20134367","journal-title":"Cancer Res"},{"issue":"1","key":"479_CR5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/gcc.2870090108","volume":"9","author":"J Karlseder","year":"1994","unstructured":"Karlseder J, Zeillinger R, Schneeberger C, Czerwenka K, Speiser P, Kubista E, Birnbaum D, Gaudray P, Theillet C (1994) Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 9(1):42\u201348","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"479_CR6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.onc.1202023","volume":"17","author":"R Hui","year":"1998","unstructured":"Hui R, Ball JR, Macmillan RD, Kenny FS, Prall OW, Campbell DH, Cornish AL, McClelland RA, Daly RJ, Forbes JF et al (1998) EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival. Oncogene 17(8):1053\u20131059","journal-title":"Oncogene"},{"issue":"5","key":"479_CR7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1101\/gad.7.5.812","volume":"7","author":"V Baldin","year":"1993","unstructured":"Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7(5):812\u2013821","journal-title":"Genes Dev"},{"issue":"3","key":"479_CR8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1023\/A:1023033708204","volume":"78","author":"CJ Ormandy","year":"2003","unstructured":"Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL (2003) Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 78(3):323\u2013335","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"479_CR9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/gcc.2870120207","volume":"12","author":"MH Champeme","year":"1995","unstructured":"Champeme MH, Bieche I, Lizard S, Lidereau R (1995) 11q13 amplification in local recurrence of human primary breast cancer. Genes Chromosomes Cancer 12(2):128\u2013133","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"479_CR10","first-page":"413","volume":"3","author":"GA Lammie","year":"1991","unstructured":"Lammie GA, Peters G (1991) Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3(11):413\u2013420","journal-title":"Cancer Cells"},{"issue":"8","key":"479_CR11","first-page":"2127","volume":"8","author":"MF Buckley","year":"1993","unstructured":"Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8(8):2127\u20132133","journal-title":"Oncogene"},{"issue":"7","key":"479_CR12","first-page":"1812","volume":"54","author":"C Gillett","year":"1994","unstructured":"Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54(7):1812\u20131817","journal-title":"Cancer Res"},{"issue":"4","key":"479_CR13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjc.6600109","volume":"86","author":"I Bieche","year":"2002","unstructured":"Bieche I, Olivi M, Nogues C, Vidaud M, Lidereau R (2002) Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Br J Cancer 86(4):580\u2013586","journal-title":"Br J Cancer"},{"issue":"6","key":"479_CR14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/bjc.1996.128","volume":"73","author":"R Michalides","year":"1996","unstructured":"Michalides R, Hageman P, van Tinteren H, Houben L, Wientjens E, Klompmaker R, Peterse J (1996) A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73(6):728\u2013734","journal-title":"Br J Cancer"},{"issue":"7","key":"479_CR15","first-page":"1177","volume":"2","author":"R Seshadri","year":"1996","unstructured":"Seshadri R, Lee CS, Hui R, McCaul K, Horsfall DJ, Sutherland RL (1996) Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Clin Cancer Res 2(7):1177\u20131184","journal-title":"Clin Cancer Res"},{"issue":"23","key":"479_CR16","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1158\/0008-5472.CAN-06-1755","volume":"66","author":"RL Kilker","year":"2006","unstructured":"Kilker RL, Planas-Silva MD (2006) Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells. Cancer Res 66(23):11478\u201311484","journal-title":"Cancer Res"},{"issue":"17","key":"479_CR17","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1158\/0008-5472.CAN-05-0746","volume":"65","author":"K Jirstrom","year":"2005","unstructured":"Jirstrom K, Stendahl M, Ryden L, Kronblad A, Bendahl PO, Stal O, Landberg G (2005) Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification. Cancer Res 65(17):8009\u20138016","journal-title":"Cancer Res"},{"issue":"46","key":"479_CR18","doi-asserted-by":"crossref","first-page":"36238","DOI":"10.1074\/jbc.M002138200","volume":"275","author":"RK Vadlamudi","year":"2000","unstructured":"Vadlamudi RK, Adam L, Wang RA, Mandal M, Nguyen D, Sahin A, Chernoff J, Hung MC, Kumar R (2000) Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 275(46):36238\u201336244","journal-title":"J Biol Chem"},{"issue":"3","key":"479_CR19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9440(10)63458-X","volume":"163","author":"P Schraml","year":"2003","unstructured":"Schraml P, Schwerdtfeger G, Burkhalter F, Raggi A, Schmidt D, Ruffalo T, King W, Wilber K, Mihatsch MJ, Moch H (2003) Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 163(3):985\u2013992","journal-title":"Am J Pathol"},{"issue":"2","key":"479_CR20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2005.08.026","volume":"100","author":"LA Brown","year":"2006","unstructured":"Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA, Chia S, Magliocco A, Makretsov N, Gilks B et al (2006) Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Gynecol Oncol 100(2):264\u2013270","journal-title":"Gynecol Oncol"},{"issue":"6","key":"479_CR21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/gcc.20549","volume":"47","author":"LA Brown","year":"2008","unstructured":"Brown LA, Kalloger SE, Miller MA, Shih I.e. M, McKinney SE, Santos JL, Swenerton K, Spellman PT, Gray J, Gilks CB et al (2008) Amplification of 11q13 in ovarian carcinoma. Genes Chromosomes Cancer 47(6):481\u2013489","journal-title":"Genes Chromosomes Cancer"},{"issue":"2\u20133","key":"479_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.febslet.2004.04.071","volume":"567","author":"S Balasenthil","year":"2004","unstructured":"Balasenthil S, Barnes CJ, Rayala SK, Kumar R (2004) Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. FEBS Lett 567(2\u20133):243\u2013247","journal-title":"FEBS Lett"},{"issue":"49","key":"479_CR23","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1038\/sj.onc.1210506","volume":"26","author":"J Bostner","year":"2007","unstructured":"Bostner J, Ahnstrom Waltersson M, Fornander T, Skoog L, Nordenskjold B, Stal O (2007) Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. Oncogene 26(49):6997\u20137005","journal-title":"Oncogene"},{"issue":"5","key":"479_CR24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0092-8674(03)00930-9","volume":"115","author":"L Hughes-Davies","year":"2003","unstructured":"Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B et al (2003) EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 115(5):523\u2013535","journal-title":"Cell"},{"issue":"5","key":"479_CR25","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","volume":"14","author":"MC Cheang","year":"2008","unstructured":"Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14(5):1368\u20131376","journal-title":"Clin Cancer Res"},{"issue":"17","key":"479_CR26","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/1078-0432.CCR-03-0410","volume":"10","author":"C Rodriguez","year":"2004","unstructured":"Rodriguez C, Hughes-Davies L, Valles H, Orsetti B, Cuny M, Ursule L, Kouzarides T, Theillet C (2004) Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome. Clin Cancer Res 10(17):5785\u20135791","journal-title":"Clin Cancer Res"},{"key":"479_CR27","doi-asserted-by":"crossref","unstructured":"Kirkegaard T, Nielsen KV, Jensen LB, Campbell FM, Muller S, Tovey SM, Brown S, Cooke TG, Bartlett JM (2008) Genetic alterations of CCND1 and EMSY in breast cancers. Histopathology 52(6):698\u2013705","DOI":"10.1111\/j.1365-2559.2008.03007.x"},{"issue":"10","key":"479_CR28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jnci\/djj185","volume":"98","author":"C Holm","year":"2006","unstructured":"Holm C, Rayala S, Jirstrom K, Stal O, Kumar R, Landberg G (2006) Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. J Natl Cancer Inst 98(10):671\u2013680","journal-title":"J Natl Cancer Inst"},{"issue":"5182","key":"479_CR29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.7939630","volume":"266","author":"PA Futreal","year":"1994","unstructured":"Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y et al (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266(5182):120\u2013122","journal-title":"Science"},{"issue":"2","key":"479_CR30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng0696-238","volume":"13","author":"JM Lancaster","year":"1996","unstructured":"Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G et al (1996) BRCA2 mutations in primary breast and ovarian cancers. Nat Genet 13(2):238\u2013240","journal-title":"Nat Genet"},{"issue":"3","key":"479_CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1005953519972","volume":"48","author":"T Sorlie","year":"1998","unstructured":"Sorlie T, Andersen TI, Bukholm I, Borresen-Dale AL (1998) Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases. Breast Cancer Res Treat 48(3):259\u2013264","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"479_CR32","first-page":"5329","volume":"60","author":"RL Baldwin","year":"2000","unstructured":"Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY (2000) BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 60(19):5329\u20135333","journal-title":"Cancer Res"},{"issue":"11","key":"479_CR33","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/sj.onc.1202509","volume":"18","author":"A Catteau","year":"1999","unstructured":"Catteau A, Harris WH, Xu CF, Solomon E (1999) Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18(11):1957\u20131965","journal-title":"Oncogene"},{"issue":"7","key":"479_CR34","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","volume":"92","author":"M Esteller","year":"2000","unstructured":"Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA et al (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92(7):564\u2013569","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"479_CR35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jnci\/94.1.61","volume":"94","author":"JP Geisler","year":"2002","unstructured":"Geisler JP, Hatterman-Zogg MA, Rathe JA, Buller RE (2002) Frequency of BRCA1 dysfunction in ovarian cancer. J Natl Cancer Inst 94(1):61\u201367","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"479_CR36","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/carcin\/21.9.1761","volume":"21","author":"JC Rice","year":"2000","unstructured":"Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW (2000) Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21(9):1761\u20131765","journal-title":"Carcinogenesis"},{"issue":"9","key":"479_CR37","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/bjc.1997.526","volume":"76","author":"N Collins","year":"1997","unstructured":"Collins N, Wooster R, Stratton MR (1997) Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. Br J Cancer 76(9):1150\u20131156","journal-title":"Br J Cancer"},{"issue":"4","key":"479_CR38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/1097-0142(20010815)92:4<787::AID-CNCR1384>3.0.CO;2-4","volume":"92","author":"E Gras","year":"2001","unstructured":"Gras E, Cortes J, Diez O, Alonso C, Matias-Guiu X, Baiget M, Prat J (2001) Loss of heterozygosity on chromosome 13q12\u2013q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors. Cancer 92(4):787\u2013795","journal-title":"Cancer"},{"issue":"18","key":"479_CR39","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jnci\/94.18.1396","volume":"94","author":"JL Hilton","year":"2002","unstructured":"Hilton JL, Geisler JP, Rathe JA, Hattermann-Zogg MA, DeYoung B, Buller RE (2002) Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst 94(18):1396\u20131406","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"479_CR40","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1056\/NEJMcibr033528","volume":"350","author":"MC King","year":"2004","unstructured":"King MC (2004) A novel BRCA2-binding protein and breast and ovarian tumorigenesis. N Engl J Med 350(12):1252\u20131253","journal-title":"N Engl J Med"},{"issue":"2","key":"479_CR41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nm0204-127","volume":"10","author":"DM Livingston","year":"2004","unstructured":"Livingston DM (2004) EMSY, a BRCA-2 partner in crime. Nat Med 10(2):127\u2013128","journal-title":"Nat Med"},{"issue":"4","key":"479_CR42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/mp.54.4.259","volume":"54","author":"SA Vaziri","year":"2001","unstructured":"Vaziri SA, Tubbs RR, Darlington G, Casey G (2001) Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers. Mol Pathol 54(4):259\u2013263","journal-title":"Mol Pathol"},{"issue":"1","key":"479_CR43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10549-004-1536-0","volume":"90","author":"J Palacios","year":"2005","unstructured":"Palacios J, Honrado E, Osorio A, Cazorla A, Sarrio D, Barroso A, Rodriguez S, Cigudosa JC, Diez O, Alonso C et al (2005) Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res Treat 90(1):5\u201314","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0479-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0479-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0479-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:32:19Z","timestamp":1559233939000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0479-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,28]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0479-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,28]]}}}